#VisualAbstract: Combination therapy using conformation-specific KIT inhibitors associated with clinical benefit in patients with advanced gastrointestinal stromal tumors
1. The use of a type I KIT inhibitor, such as PLX9486, in combination with a type II inhibitor, such ...
